| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |